1
|
Krishnaswamy A, Isogai T, Brilakis ES, Nanjundappa A, Ziada KM, Parikh SA, Rodés-Cabau J, Windecker S, Kapadia SR. Same-Day Discharge After Elective Percutaneous Transcatheter Cardiovascular Interventions. JACC Cardiovasc Interv 2023; 16:1561-1578. [PMID: 37438024 DOI: 10.1016/j.jcin.2023.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 04/23/2023] [Accepted: 05/08/2023] [Indexed: 07/14/2023]
Abstract
Percutaneous transcatheter interventions have evolved as standard therapies for a variety of cardiovascular diseases, from revascularization for atherosclerotic vascular lesions to the treatment of structural cardiac diseases. Concomitant technological innovations, procedural advancements, and operator experience have contributed to effective therapies with low complication rates, making early hospital discharge safe and common. Same-day discharge presents numerous potential benefits for patients, providers, and health care systems. There are several key elements that are shared across the spectrum of interventional cardiology procedures to create a successful same-day discharge pathway. These include appropriate patient and procedure selection, close postprocedural observation, predischarge assessments specific for each type of procedure, and the existence of a patient support system beyond hospital discharge. This review provides the rationale, available data, and a framework for same-day discharge across the spectrum of coronary, peripheral, and structural cardiovascular interventions.
Collapse
Affiliation(s)
- Amar Krishnaswamy
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Toshiaki Isogai
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Emmanouil S Brilakis
- Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
| | - Aravinda Nanjundappa
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Khaled M Ziada
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Sahil A Parikh
- Division of Cardiology and Center for Interventional Vascular Therapy, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA
| | - Josep Rodés-Cabau
- Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada
| | - Stephan Windecker
- Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - Samir R Kapadia
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
| |
Collapse
|
2
|
Wiechmann BN. Peripheral Arterial Disease Treatment in the Non-Hospital Setting. Semin Intervent Radiol 2023; 40:193-196. [PMID: 37333743 PMCID: PMC10275662 DOI: 10.1055/s-0043-57265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/20/2023]
Abstract
Treatment of peripheral artery disease (PAD) has undergone a progressive shift toward less invasive, endovascular options within the last three decades. For PAD patients, the benefits of this shift are numerous and include less periprocedural pain, decreased blood loss, shorter recovery times, and fewer missed workdays. Commonly, patient-reported outcomes are very positive with this "endovascular first" strategy and the number of open surgical procedures for various stages of PAD has declined steadily over the last 20 years. Coincident with this trend is the move toward "ambulatory" lower extremity arterial intervention (LEAI) in the hospital outpatient "same-day" department. The next logical extension was then performing LEAI in a true physician office-based lab (OBL), ambulatory surgical center (ASC), or "non-hospital setting." This article examines these trends and the concept that the OBL/ASC provides a safe, alternative site of service for PAD patients requiring LEAI.
Collapse
|
3
|
Chaturvedi A, Castro-Dominguez Y, Gertz ZM, Lawson BD, Chandrika P, Gupta R, Milioglou I, Sung JG, Desai NR, Vetrovec G, Kochar A, Guha A. Patterns of Care and Outcomes of Ambulatory Endovascular Interventions in Lower Extremity Peripheral Arterial Disease. Am J Cardiol 2023; 194:17-26. [PMID: 36924641 DOI: 10.1016/j.amjcard.2023.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/25/2022] [Revised: 01/18/2023] [Accepted: 02/06/2023] [Indexed: 03/18/2023]
Abstract
Lower extremity endovascular intervention (LE-EVI) is gaining popularity as the primary treatment modality for patients with symptomatic peripheral artery disease refractory to noninvasive management. We examined the contemporary patterns of care, regional variation, and outcomes of ambulatory LE-EVI in the United States. The National Ambulatory Surgery Sample was analyzed to identify 266,563 records with peripheral artery disease and LE-EVI between January 1, 2016 and December 31, 2017. The mean age of the study cohort was 68.9 years and 40.5% were women. The majority of the endovascular interventions were performed at large (58.1%), urban teaching (64.1%), private not-for-profit (76.8%) centers, and the southern region accounted for most cases (43%). Periprocedural major adverse renal and cardiovascular events and other complications were 0.5% and 3.3%, respectively. Most patients (97.6%) were discharged home after the procedure. Age, female gender, uncontrolled hypertension, ischemic heart disease, heart failure, arrhythmia, chronic kidney disease, malnutrition, non-Medicare insurance, private for-profit, urban teaching facilities, and southern and midwest regions were associated with higher odds of major adverse renal and cardiovascular events. The mean charges per patient encounter were $56,500, with significant differences across various patient and facility characteristics. In conclusion, our study demonstrates the use, patterns of care, financial aspect, and overall safety of ambulatory LE-EVIs in a real-world setting.
Collapse
Affiliation(s)
| | | | - Zachary M Gertz
- Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia
| | - Barbara D Lawson
- Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia
| | - Parul Chandrika
- Department of Medicine, East Carolina University, Greenville, North Carolina
| | - Rahul Gupta
- Division of Cardiology, Lehigh Valley Health Network, Allentown, Pennsylvania
| | | | - Jonathan G Sung
- Division of Cardiology, Brigham & Women's Hospital, Boston, Massachusetts
| | - Nihar R Desai
- Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut
| | - George Vetrovec
- Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia
| | - Ajar Kochar
- Division of Cardiology, Brigham & Women's Hospital, Boston, Massachusetts
| | - Avirup Guha
- Division of Cardiology, Medical College of Georgia, Augusta, Georgia
| |
Collapse
|
4
|
Kikuchi S, Uchida D, Takahashi K, Yoshida Y, Tochikubo-Suzuki A, Nakatsu T, Higuchi M, Azuma N, Kato K. Wound Healing on the Cutting Plane of Ankle Bones after Incomplete Revascularization for Chronic Limb-Threatening Ischemia in an Elderly Patient: A Case Report. Ann Vasc Dis 2022; 15:201-205. [PMID: 36310735 PMCID: PMC9558140 DOI: 10.3400/avd.cr.22-00049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Accepted: 06/18/2022] [Indexed: 11/16/2022] Open
Abstract
Chronic limb-threatening ischemia (CLTI) is an important issue for elderly patients with peripheral artery disease. Here, we present the case of a 91-year-old man with CLTI, residing in a rural district. The onset of CLTI rapidly deprived him of ambulation because of a foot infection. Given that he had difficulty with long-distance transportation, limb salvage for extensive tissue loss was performed at a district facility, based on his and his family’s request. Finally, skin grafting on the cutting plane of the right ankle bones resulted in wound healing in six months after incomplete revascularization and multiple minor amputations.
Collapse
Affiliation(s)
| | - Daiki Uchida
- Department of Vascular Surgery, Asahikawa Medical University
| | | | - Yuri Yoshida
- Department of Vascular Surgery, Asahikawa Medical University
| | | | - Tomoki Nakatsu
- Department of Vascular Surgery, Asahikawa Medical University
| | | | - Nobuyoshi Azuma
- Department of Vascular Surgery, Asahikawa Medical University
| | | |
Collapse
|
5
|
Rodway A, Stafford M, Wilding S, Ntagiantas N, Patsiogiannis V, Allan C, Field B, Clark J, Casal FP, Pankhania A, Loosemore T, Heiss C. Day case angioplasty in a secondary care setting - initial experience. VASA 2021; 50:202-208. [PMID: 33599142 DOI: 10.1024/0301-1526/a000942] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Background: Peripheral artery disease presents an increasing healthcare burden worldwide. Day-case angioplasty in a secondary care setting can be a safe and effective means of meeting the growing demand for lower limb revascularisation. We evaluated the safety and efficacy of a day-case-based angioplasty service in a UK district general hospital. Patients and methods: Consecutive patients undergoing endovascular revascularisation between August 2018-February 2020 were analysed retrospectively. All patients were discussed at a multi-disciplinary (diabetic foot) team meeting following a day case algorithm. Patient and procedural characteristics, technical success, peri-procedural complications, and 30-day outcome of day-case angioplasties were compared with those requiring overnight stay or were hospitalized. Results: Fifty-seven percent of 138 patients were diabetic, mean age 75 ± 12 years, 95% had critical limb ischaemia (Fontaine III 12%, IV 83%), and baseline ankle brachial pressure index [ABPI] 0.40 ± 0.30. Sixty-three patients (45%) were treated as planned day cases, 21 (15%) required overnight admission for social indications. Fifteen (11%) were planned admissions with the need for sequential debridement procedures, and 39 (28%) were already hospitalised at the time of referral to the vascular service. The overall technical success was 92% and not successful procedures mainly occurred in patients > 80 years. The ABPI increased at the initial follow-up to 0.84 ± 0.18. Fifty-three percent required treatment of > 1 level, 80% included recanalisations of chronic total occlusions, and average total lesion length was 133 ± 90 mm. Closure devices were employed in all cases. There were no major peri-procedural complications. A single minor access-site related bleeding episode (0.8%) occurred, requiring 24 h observation in hospital. While significantly more wounds had closed in out-patients, the mortality, major amputation and target lesion revascularization did not differ between groups. Conclusions: Safe and effective day-case-based angioplasty can be provided in a secondary care setting for patients with critical limb ischaemia needing complex multi-level procedures.
Collapse
Affiliation(s)
- Alexander Rodway
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - Michelle Stafford
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,First Community Health and Care, Redhill, UK
| | - Sophie Wilding
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,Section of Clinical Medicine, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK
| | - Nikolaos Ntagiantas
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,St George's University Hospitals NHS Foundation Trust, London, UK
| | - Vasileios Patsiogiannis
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,St George's University Hospitals NHS Foundation Trust, London, UK
| | - Charlotte Allan
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - Ben Field
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,Section of Clinical Medicine, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK
| | - James Clark
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK
| | | | | | - Thomas Loosemore
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,St George's University Hospitals NHS Foundation Trust, London, UK
| | - Christian Heiss
- Surrey and Sussex Healthcare NHS Trust, Redhill, UK.,Section of Clinical Medicine, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK
| |
Collapse
|